These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7184392

  • 1. [NK activities in cancer patients--their modification by an immunopotentiator].
    Sasanami T, Fujishima A, Moriya Y, Imai K, Yachi A.
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
    [Abstract] [Full Text] [Related]

  • 2. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
    Oshita H, Saji S, Sugiyama Y, Tanemura H, Sakata K, Tanaka S, Ito T.
    Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
    [Abstract] [Full Text] [Related]

  • 3. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H, Kasahara T, Minato N, Hamuro J, Miyata M, Morioka Y.
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [Abstract] [Full Text] [Related]

  • 4. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB.
    Nat Immun Cell Growth Regul; 1987 Oct; 6(5):224-36. PubMed ID: 3444437
    [Abstract] [Full Text] [Related]

  • 5. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y, Ohgaki K, Tsuchitani T, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug 20; 24(8):1607-15. PubMed ID: 2809385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Correlation between enhancement of natural killer (NK) activity by an immunopotentiator (OK-432) and resistance to human hepatoma cell implantation in nude mice].
    Saito H, Morizane T, Kumagai N, Inagaki Y, Nakamura T, Satoh I, Iino A, Matsumura S, Kawamura N, Tsuchiya M.
    Nihon Shokakibyo Gakkai Zasshi; 1985 Dec 20; 82(12):2923-9. PubMed ID: 3831444
    [No Abstract] [Full Text] [Related]

  • 9. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
    Wakasugi H, Oshimi K, Miyata M, Morioka Y.
    J Clin Immunol; 1981 Jul 20; 1(3):154-62. PubMed ID: 6174541
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. III. Experimental study using human peripheral neutrophils].
    Umemoto T, Saji S, Enami H, Kunii Y, Goshima H, Tachibana S, Takao H, Sakata K.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul 20; 23(7):1518-24. PubMed ID: 3183460
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
    Vinzenz K, Matejka M, Watzek G, Porteder H, Neuhold N, Micksche M.
    Cancer Detect Prev Suppl; 1987 Jul 20; 1():463-75. PubMed ID: 3480060
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K, Kano S, Takaku F, Okumura K.
    J Natl Cancer Inst; 1980 Dec 20; 65(6):1265-9. PubMed ID: 7001124
    [Abstract] [Full Text] [Related]

  • 17. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F, Iwagaki H, Gouchi A, Hizuta A, Isozaki H, Takakura N, Tanaka N.
    J Med; 1998 Dec 20; 29(3-4):199-215. PubMed ID: 9865458
    [Abstract] [Full Text] [Related]

  • 18. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
    Fujieda S, Saito H, Isobe Y, Nakagawara G, Nishi O, Nagahara K, Watanabe Y, Hoshino T.
    Anticancer Res; 1992 Dec 20; 12(6B):1941-5. PubMed ID: 1341892
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.